1st Quarter - Report · 2026

Filing UUID: 3321ae7c-90a5-4e60-975d-e9ee94cf6095
Type: Q1 — 1st Quarter - Report
Period: first_quarter
Year: 2026
Posted: 2026-04-09 17:29:35
Income (reported): $60,000
Expenses (reported): —
Filing document: Open on lda.senate.gov

Registrant (lobbying firm)

KOUNTOUPES DENHAM CARR & REID, LLC

Federal lobbying and consulting services

Contact: PAULA M. SHORT
Phone: +1 202-803-4585
Address: zip:20005, city:Washington, state:DC, street:607 - 14th Street NW Suite 750

Client

BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY)

Non profit dedicated to funding blood cancer research.

State: DC
Country: US
Government-entity client: false
Effective date: 2016-01-01

Issues lobbied + lobbyists

`HCR` — Health Issues

Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to agency finding for medical and cancer research, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to pediatric drug development.

Lobbyists: LORI DENHAM; JULIE HERSHEY CARR; ms MARY DEE BEAL; LESLIE ZELENKO

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

`MMM` — Medicare/Medicaid

Issues related to blood cancer research for adult and pediatric populations, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to health coverage and patient access to care.

Lobbyists: LORI DENHAM; JULIE HERSHEY CARR; ms MARY DEE BEAL; LESLIE ZELENKO

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

`TAX` — Taxation/Internal Revenue Code

Issues related to the tax treatment of charitable contributions.

Lobbyists: ms MARY DEE BEAL

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.